Lexicon Pharmaceuticals Reports Results for Quarter Ended June 30, 2026

What Happened
Lexicon Pharmaceuticals, Inc. (LXRX) filed a Form 8-K on August 6, 2026 to report its financial results for the quarter ended June 30, 2026. The company issued a press release with those results, which is attached to the 8-K as Exhibit 99.1. The filing notes the press release and related inline XBRL cover page exhibit but states the information is not “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference in other filings except where expressly stated.

Key Details

• Filing date: August 6, 2026; reporting period: quarter ended June 30, 2026.
• Press release reporting the quarter’s financial results is attached as Exhibit 99.1.
• EX-104 (Cover Page Interactive Data File) is included (inline XBRL).
• Form 8-K signed by Brian T. Crum, Senior Vice President and General Counsel.

Why It Matters
This 8-K announces that Lexicon has publicly released its latest quarterly results—important for investors tracking revenue, earnings, cash position, and program updates. The 8-K itself does not include detailed financial tables in the filing text; investors should read the attached press release and look for the company’s forthcoming quarterly report (e.g., 10‑Q) for full financial statements and additional disclosures. Tracking these releases helps investors assess near-term performance and upcoming catalysts.